Morrisville clinical-stage biotech engineering bacteriophage therapeutics with CRISPR-Cas3 payloads for antimicrobial-resistant bacterial infections and microbiome / inflammatory diseases.
At a glance
- Founded: 2015
- HQ: Morrisville
- Sector: Biotech
- Stage: Series B
- Total raised: $35M
- Affiliation: NC State
See the full company record.
Founders, funding history and recent signals. Free accounts open immediately.
Sourced company notes 4 topics
Notes on Locus Biosciences · last checked Oct 1, 2026
Overview
Science
Funding
Team
Where the team studied
Filter the directory by schoolDuke University
- Dave OusteroutAlumPh.D., Biomedical Engineering
North Carolina State University
- Chase BeiselFacultyAssistant Professor (later Associate Professor with tenure), Department of Chemical and Biomolecular EngineeringSource
- Paul GarofoloFacultyVisiting Professor, Poole College of ManagementSource
- Rodolphe BarrangouFacultyProfessor of Food ScienceSource
Each line was checked against a primary source. Founder education is recorded for part of the directory, so a name missing here is a gap in what has been checked, not a statement that they studied somewhere else. Tell me what is missing.
Listed roles
All Triangle rolesChecking listed roles…